CD79A and nonpapillary renal cell carcinoma: Mature TLS within tumors participate in antitumor immunity and might serve as the locale for the generation of IgA and IgG plasma cell, predicting favorable prognosis and effectiveness of immunotherapy, whereas peritumoral immature TLS show opposite effects for ccRCC patients subjected to immunotherapy.